Envista Holdings Corporation (NYSE:NVST – Get Free Report) has been assigned an average rating of “Hold” from the seventeen analysts that are currently covering the firm, Marketbeat Ratings reports. Eleven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $29.00.
A number of research analysts have recently issued reports on NVST shares. Wall Street Zen downgraded shares of Envista from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. UBS Group lifted their price target on shares of Envista from $27.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, November 5th. Mizuho set a $29.00 price objective on shares of Envista in a research report on Thursday, August 6th. Deutsche Bank set a $32.00 price objective on shares of Envista in a research note on Thursday, September 3rd. Finally, Piper Sandler cut their price target on Envista from $28.00 to $26.00 and set a “neutral” rating on the stock in a report on Friday, October 9th.
Get Our Latest Stock Report on Envista
Insiders Place Their Bets
In other Envista news, SVP Mischa Reis sold 8,000 shares of the firm’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the sale, the senior vice president directly owned 27,321 shares in the company, valued at approximately $751,327.50. This trade represents a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Envista
Several hedge funds and other institutional investors have recently modified their holdings of the company. Covestor Ltd increased its holdings in shares of Envista by 14.9% in the 3rd quarter. Covestor Ltd now owns 3,882 shares of the company’s stock worth $91,000 after acquiring an additional 502 shares during the period. Parallel Advisors LLC lifted its position in Envista by 16.9% in the first quarter. Parallel Advisors LLC now owns 3,710 shares of the company’s stock worth $94,000 after purchasing an additional 535 shares during the period. Tidal Investments LLC boosted its stake in Envista by 2.4% during the second quarter. Tidal Investments LLC now owns 23,555 shares of the company’s stock valued at $621,000 after buying an additional 547 shares in the last quarter. Abel Hall LLC boosted its position in shares of Envista by 4.7% during the 3rd quarter. Abel Hall LLC now owns 12,513 shares of the company’s stock valued at $294,000 after purchasing an additional 562 shares in the last quarter. Finally, CenterBook Partners LP grew its position in Envista by 2.2% in the third quarter. CenterBook Partners LP now owns 26,441 shares of the company’s stock worth $621,000 after buying an additional 581 shares during the last quarter.
Envista Trading Down 1.9%
NYSE:NVST opened at $25.36 on Thursday. The stock has a market cap of $4.07 billion, a price-to-earnings ratio of 6.55, a price-to-earnings-growth ratio of 1.23 and a beta of 0.94. Envista has a one year low of $18.77 and a one year high of $30.42. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.10 and a current ratio of 2.45. The business’s 50-day simple moving average is $24.31 and its 200 day simple moving average is $25.76.
Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. The company had revenue of $691.50 million during the quarter, compared to analyst estimates of $688.74 million. Envista had a net margin of 22.01% and a return on equity of 8.26%. The firm’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period last year, the business earned $0.32 EPS. As a group, sell-side analysts predict that Envista will post 1.56 earnings per share for the current fiscal year.
Envista Company Profile
Envista Holdings Corporation is a dental products and technology company that develops and supplies tools and services for dental professionals. Its offerings span implant dentistry, orthodontics, digital imaging, restorative care and other clinical applications. The company’s products include dental implants and related treatment systems, orthodontic brackets and clear aligners, imaging equipment and software, and restorative and endodontic materials. Its brands include Nobel Biocare, Ormco, DEXIS, Kerr and KaVo.
Recommended Stories
- Five stocks we like better than Envista
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
